3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Enrolling by invitation
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Breast
1
Conditions
Mucositis
1
Esophagitis
1
Breast Neoplasms
1
Interventions
Tamoxifen
10
Docetaxel
8
Trastuzumab
7
Paclitaxel
6
Letrozole
6
Gemcitabine
6
Exercise
6
Control Groups
6
exemestane
5
Indocyanine Green
5
Cyclophosphamide
5
Carboplatin
5
Anastrozole
5
pertuzumab
4
dalpiciclib
4
Vinorelbine
4
Doxorubicin
4
Capecitabine
4
pyrotinib
3
Surgical Procedures, Operative
3
Standard of Care
3
Radiotherapy
3
Radiation
3
Mammography
3
Fulvestrant
3
Cisplatin
3
ferumoxides
2
Zoledronic Acid
2
Tablets
2
Surveys and Questionnaires
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER_GOV
×
Breast Neoplasms
×
Alginates
×
Clear all
NCT06958445
2025-05-06
SAFE
Taipei City Hospital
Phase 2
Enrolling by invitation
90 enrolled